Deprescribing and Polypharmacy in an Aging Population

Name: Deprescribing and Polypharmacy in an Aging Population
SKU: 50391cce599028a4cebc2728f1aceec6
Price: 139 EUR
Availability: InStock

1/1

Afbeelding van Deprescribing and Polypharmacy in an Aging Population

Bol

Prijzen vanaf

139,00

Uitgelicht

	139,00	Naar shop
VERGELIJK ALLE AANBIEDERS (1)

Beschrijving

Bol Deprescribing and Polypharmacy in an Aging Population supports healthcare professionals across global healthcare institutions in reducing polypharmacy-related drug replated problems (DRPs) by working with patients, families, interprofessional healthcare professionals, and educational institutions to develop, implement, test, improve upon, and educate on strategies for deprescribing and optimizing patient safety. Polypharmacy, the use of multiple medications at the same time by one person, is very common in various patient populations, including those who lack primary physicians, patients with mental health conditions, patients with multiple chronic conditions, and in the aging population. - Emphasizes the importance of involving a multidisciplinary team in deprescribing efforts - Identifies barriers and enablers for the implementation of deprescribing programs - Develops strategies to address barriers and optimize enablers for deprescribing implementation

Lees meer

Vergelijk aanbieders (1)

Sorteren op:

€ 139,00 Gratis verzending

Beschrijving (1)

Deprescribing and Polypharmacy in an Aging Population supports healthcare professionals across global healthcare institutions in reducing polypharmacy-related drug replated problems (DRPs) by working with patients, families, interprofessional healthcare professionals, and educational institutions to develop, implement, test, improve upon, and educate on strategies for deprescribing and optimizing patient safety. Polypharmacy, the use of multiple medications at the same time by one person, is very common in various patient populations, including those who lack primary physicians, patients with mental health conditions, patients with multiple chronic conditions, and in the aging population. - Emphasizes the importance of involving a multidisciplinary team in deprescribing efforts - Identifies barriers and enablers for the implementation of deprescribing programs - Develops strategies to address barriers and optimize enablers for deprescribing implementation

Lees meer